Brief: Cancer Genetics Reports Q2 Loss Per Share $0.82

Vyant Bio

14/08/2020 13:03

Aug 14 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.82 FROM CONTINUING OPERATIONS
    * Q2 REVENUE FELL 5 PERCENT TO $1.4 MILLION

Source text for Eikon:  ID:nGNX4x3sQP 
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))